Expression analysis of p16 and TOP2A protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania
Open Access
- 27 October 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (10) , e0259096
Abstract
Biomarkers yield important information for early diagnosis of cervical cancer. However, they are rarely applied for prognosis of cervical cancer in Tanzania, where visual inspection assay with acetic acid or Lugol’s iodine and Pap test are being used as the standard screening/ diagnostic methods. This was a retrospective hospital-based cross-sectional study that was conducted to assess cyclin-dependent kinase inhibitor (p16) and topoisomerase II-alpha (TOP2A) proteins expression among women seeking cervical cancer care at Kilimanjaro Christian Medical Centre, Tanzania between May 1, 2017 and May 10, 2018. Immunohistochemistry technique was used to detect the expressions of p16 and TOP2A proteins from the retrieved formalin-fixed and paraffin-embedded (FFPE) cervical biopsies. A total of 145 patients, with a mean age of 52.1 ± 12.9 years, were included in this study. Upon immunohistochemistry staining, 103 (71.0%) and 90 (62.1%) were p16 and TOP2A positive respectively. There was a strong association between histopathological class and p16/TOP2A expression levels (Fisher’s exact test, pp = 0.006 and 0.005, respectively). The age-adjusted odds ratio for predicting cervical cancer lesions were independently significant for p16/TOP2A biomarkers in FFPE cervical tissues [p16: OR = 1.142 (95% CI: 1.059–1.232, pp = 0.015)]. Importantly, the diagnostic performance of p16 was higher than that of TOP2A in the diagnosis of cancerous lesions from non-cancerous cervical lesions (sensitivity: 97.2% versus 77.6%, accuracy: 92.8% versus 87.8%, respectively). Our study has highlighted that over-expression of TOP2A is related to the grade of cervical intraepithelial neoplasia but does not predict prognosis in cervical cancer. Similarly, expression of p16 is related to degree of histological dysplasia and malignancy, suggesting its prognostic and predictive value in the management of cervical cancers. Further bigger studies are needed to validate their applications in the early diagnosis of cervical cancer.Keywords
Funding Information
- World Bank under the CREATES-FNS project at NM-AIST (02090107-048-301-4001-P044-J01S01-C42)
This publication has 42 references indexed in Scilit:
- Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high‐grade cervical lesions in HIV positive and HIV negative Tanzanian womenInternational Journal of Cancer, 2014
- Promoters of and barriers to cervical cancer screening in a rural setting in TanzaniaInternational Journal of Gynecology & Obstetrics, 2013
- Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical CancerPLOS ONE, 2013
- Role of Protein Biomarkers in the Detection of High-Grade Disease in Cervical Cancer Screening ProgramsJournal of Oncology, 2012
- Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: Three public policy implicationsBMC Public Health, 2012
- Internal construct validity of the Shirom-Melamed Burnout Questionnaire (SMBQ)BMC Public Health, 2012
- Biomarkers of Cervical Dysplasia and CarcinomaJournal of Oncology, 2011
- Human Papillomavirus and Cervical Cancer: Biomarkers for Improved Prevention EffortsFuture Microbiology, 2011
- Evaluation of cervical visual inspection screening in Dar es Salaam, TanzaniaInternational Journal of Gynecology & Obstetrics, 2010
- p16INK4A expression in cervical premalignant and malignant lesionsExperimental and Molecular Pathology, 2006